The rising interest in GLP-1 agonists for metabolic conditions has sparked a debate about application forms : skin-applied devices versus pills . Typically, GLP-1 therapies were exclusively available in https://brontelqlr135041.ka-blogs.com/94402577/glp-1-transdermal-delivery-systems-vs-pills-what-best-for-you